The Russian ‘Sputnik V’ vaccine

Do Americans trust it?

Russia’s announcement of its first coronavirus vaccine earlier this month met with a lot of controversy and speculations, especially from the global scientific community. This report delves into the views of ordinary Americans, especially given the devastating consequences they have continued to witness. Drug manufacturers, as well as government agencies, can leverage this data in their decision making.

Nearly nine months into the Covid-19 outbreak, Russia became the first country to approve the first coronavirus vaccine, “Sputnik V,” putting it in the lead in the global vaccine race. However, skepticism regarding its safety and effectiveness continues to abound, even as other governments rush to meet the demand. With the US death toll nearing a shocking 200000, Americans, for one, are looking for some respite. But how trusting are they of Russia’s ‘superfast’ vaccine? Piplsay polled 30,413 people nationwide to get these insights. Here’s a summary of what we found:

Other Insights

• More men (64%) are keen to believe in Russia’s vaccine success as compared to women (36%)
• 82% of Baby boomers and 63% of Gen Xers do not trust Russia’s ‘Sputnik V’ vaccine as of now
• 50% of Millennials and 47% of Gen Xers fear the Russian vaccine may force countries to bypass due processes
• 56% of whites and 43% of blacks are quite interested in getting a COVID-19 vaccine if one becomes available

Survey Methodology: This Piplsay survey (powered by Market Cube) was conducted nationwide in the US from August 18-19, 2020. We received 30,413 online responses from individuals aged 18 years and older.